These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. Abraham E; Wunderink R; Silverman H; Perl TM; Nasraway S; Levy H; Bone R; Wenzel RP; Balk R; Allred R JAMA; 1995 Mar 22-29; 273(12):934-41. PubMed ID: 7884952 [TBL] [Abstract][Full Text] [Related]
7. Establishment of a pneumococcal septicemia model in the miniature swine. Izbicki JR; Raedler C; Ruckdeschel G; Lütticken R; Wilker DK; Siebeck M; Dornschneider G; Sklarek J; Schweiberer L; Ziegler-Heitbrock HW Zentralbl Veterinarmed A; 1992 Mar; 39(2):152-9. PubMed ID: 1590038 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis. Opal SM; Cross AS; Sadoff JC; Collins HH; Kelly NM; Victor GH; Palardy JE; Bodmer MW J Clin Invest; 1991 Sep; 88(3):885-90. PubMed ID: 1885775 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of splenic macrophage tumor necrosis factor alpha secretion in vivo by antilipopolysaccharide monoclonal antibodies. Battafarano RJ; Burd RS; Kurrelmeyer KM; Ratz CA; Dunn DL Arch Surg; 1994 Feb; 129(2):179-80. PubMed ID: 8304828 [TBL] [Abstract][Full Text] [Related]
11. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Fisher CJ; Opal SM; Dhainaut JF; Stephens S; Zimmerman JL; Nightingale P; Harris SJ; Schein RM; Panacek EA; Vincent JL Crit Care Med; 1993 Mar; 21(3):318-27. PubMed ID: 8440099 [TBL] [Abstract][Full Text] [Related]
12. Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis--a randomized, clinical trial. Clark MA; Plank LD; Connolly AB; Streat SJ; Hill AA; Gupta R; Monk DN; Shenkin A; Hill GL Crit Care Med; 1998 Oct; 26(10):1650-9. PubMed ID: 9781721 [TBL] [Abstract][Full Text] [Related]
13. Plasma tumor necrosis factor levels in patients with presumed sepsis. Results in those treated with antilipid A antibody vs placebo. de Groote MA; Martin MA; Densen P; Pfaller MA; Wenzel RP JAMA; 1989 Jul; 262(2):249-51. PubMed ID: 2739019 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. Reinhart K; Wiegand-Löhnert C; Grimminger F; Kaul M; Withington S; Treacher D; Eckart J; Willatts S; Bouza C; Krausch D; Stockenhuber F; Eiselstein J; Daum L; Kempeni J Crit Care Med; 1996 May; 24(5):733-42. PubMed ID: 8706447 [TBL] [Abstract][Full Text] [Related]
15. Release of endothelin in relation to tumor necrosis factor-alpha in porcine Pseudomonas aeruginosa-induced septic shock. Han JJ; Windsor A; Drenning DH; Leeper-Woodford S; Mullen PG; Bechard DE; Sugerman HJ; Fowler AA Shock; 1994 May; 1(5):343-6. PubMed ID: 7743336 [TBL] [Abstract][Full Text] [Related]
17. Myocardial and vascular adrenergic alterations in a rat model of endotoxin shock: reversal by an anti-tumor necrosis factor-alpha monoclonal antibody. Boillot A; Massol J; Maupoil V; Grelier R; Bernard B; Capellier G; Berthelot A; Barale F Crit Care Med; 1997 Mar; 25(3):504-11. PubMed ID: 9118669 [TBL] [Abstract][Full Text] [Related]
18. Anti-L-selectin antibody therapy does not worsen the postseptic course in a baboon model. Redl HR; Martin U; Khadem A; Pelinka LE; van Griensven M Crit Care; 2005; 9(6):R735-44. PubMed ID: 16356222 [TBL] [Abstract][Full Text] [Related]
19. Effect of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis. Wellmer A; Gerber J; Ragheb J; Zysk G; Kunst T; Smirnov A; Brück W; Nau R Infect Immun; 2001 Nov; 69(11):6881-6. PubMed ID: 11598062 [TBL] [Abstract][Full Text] [Related]
20. Anti-tumor necrosis factor antibody impairs the therapeutic effect of ceftriaxone in murine pneumococcal pneumonia. Rijneveld AW; Florquin S; Hartung T; Speelman P; van der Poll T J Infect Dis; 2003 Jul; 188(2):282-5. PubMed ID: 12854084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]